<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01085669</url>
  </required_header>
  <id_info>
    <org_study_id>EKBB 304/09</org_study_id>
    <nct_id>NCT01085669</nct_id>
  </id_info>
  <brief_title>Infection Rate of Vertical Expandable Prosthetic Titanium Rib Implants (VEPTR)</brief_title>
  <official_title>Infection Rate of VEPTR-Implants in Children With Severe Spinal and Thoracic Deformities</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Vaudois</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Children's Hospital Basel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire Vaudois</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is conducted to analyse the infection rate in children treated with VEPTR-Implants
      for severe spine or thoracic deformities.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Spinal and thoracic deformities in children can be treated with vertical expandable
      prosthetic titanium ribs (VEPTR©, Synthes GmbH®) to stimulate thoracic and spinal growth.
      With these implants children's symptoms and conditions can be slowed, halted or even
      reversed. Because of the dynamic character of the deformity and the growth of the children,
      the implants have to be lengthened about every half a year. With each operation there is a
      small risk of infection, which might increase with number of previous surgeries. Implant
      associated infections are often not clinical apparent and only found in microbiological
      analysis. To objectify the infection rate, identify potential precursors of infections and
      the relevance of asymptomatic infections in children with these implants a prospective study
      is conducted.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2009</start_date>
  <completion_date type="Anticipated">May 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Infection rate of VEPTR Implants</measure>
    <time_frame>two years</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Infection</condition>
  <arm_group>
    <arm_group_label>VEPTR patients</arm_group_label>
    <description>Children treated with VEPTR Implants for severe spinal or thoracic deformities</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Microbiological analysis of retained VEPTR Implants</intervention_name>
    <description>Implants have to be adapted every half a year, the retained implants during revision are analysed for biological colonization.</description>
    <arm_group_label>VEPTR patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children with severe spinal or throacic deformities treates with VEPTR-implants. In these
        patients the implant has to be revised every half a year due to grow and achieved
        correction.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all patients admitted at the University Children's Hospital Basel in whom a
             VEPTR©-implant or parts of it will be removed.

        Exclusion Criteria:

          -  obvious contamination of an explanted component occurred in the operating room.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christian Plaass, MD</last_name>
    <phone>+49 152 29098211</phone>
    <email>Christian@Plaass.info</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carol Claudius Hasler, MD, PhD</last_name>
    <phone>+41 685 5350</phone>
    <email>Carolclaudius.hasler@ukbb.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Orthopaedic Department, University Children´s Hospital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4005</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Studer, MD</last_name>
      <phone>+41 685 6565</phone>
      <email>Daniel.Studer@ukbb.ch</email>
    </contact>
    <contact_backup>
      <last_name>Carol Claudius Hasler, MD, PhD</last_name>
      <phone>+41 685 5350</phone>
      <email>Carolclaudius.hasler@ukbb.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Daniel Studer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 11, 2010</study_first_submitted>
  <study_first_submitted_qc>March 11, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 12, 2010</study_first_posted>
  <last_update_submitted>March 11, 2010</last_update_submitted>
  <last_update_submitted_qc>March 11, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 12, 2010</last_update_posted>
  <responsible_party>
    <name_title>PD Dr. Carol-C. Hasler, Head Spine Surgery</name_title>
    <organization>Orthopaedic Department, University Children´s Hospital Basel</organization>
  </responsible_party>
  <keyword>Infection rate of VEPTR-Implants</keyword>
  <keyword>VEPTR. Vertical Expandable</keyword>
  <keyword>Prosthetic Titanium Rib</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

